What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...
Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...
Please provide your email address to receive an email when new articles are posted on . FDA drug approvals have led to significant advancement in endometrial cancer treatment. Stage and histology ...
Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...
In summary, the treatment of endometrial cancer is rapidly evolving. An extensive body of literature exists which, upon critical review, has shaped the current treatment paradigms. New minimally ...
Side effects depend on treatment type, and it’s important to tell your healthcare provider if you notice any. “Patients should be familiar with what signs and symptoms to monitor ‌and feel encouraged ...
Fibroids and uterine cancer can both cause growths to form in the uterus. Certain symptoms can also overlap. A doctor can determine whether you have fibroids or uterine cancer. Fibroids are benign ...
This comprehensive guide explores endometrial cancer symptoms, risk factors, and the latest treatment options available, ...
Understanding the early signs of endometrial cancer coming back is important. Being aware, attending check-ups, and acting quickly can make a huge difference. Here’s how with timely care and modern ...
Researchers have found in a cohort study that patients with early-stage, low-grade endometrial cancer who did not undergo ...
She was the most outgoing caring person in the world in September 2020. At the age of 63 Sherlyn Webb was diagnosed with uterine cancer but was told the disease had been caught early. We thought that ...